| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
13,870,000 |
| Market
Cap: |
362.98(M) |
| Last
Volume: |
31,837 |
Avg
Vol: |
64,577 |
| 52
Week Range: |
$17.67 - $38.49 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures vascular intervention medical device products and is engaged in Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
9,872 |
| Total Sell Value |
$0 |
$0 |
$0 |
$335,339 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Knight Susan E |
Director |
– • – |
2022-02-28 |
4 |
OE |
$20.18 |
$88,106 |
D/D |
4,366 |
34,562 |
|
- |
|
| Sultana Nusrath |
VP, Clinical Affairs |
• – – |
2022-02-12 |
4 |
D |
$41.67 |
$31,753 |
D/D |
(762) |
6,530 |
|
- |
|
| Knight Susan E |
Director |
– • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,482 |
30,196 |
|
- |
|
| Heine Lisa Wipperman |
Director |
– • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,375 |
9,666 |
|
- |
|
| Dantzker David |
Director |
– • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,375 |
32,585 |
|
- |
|
| Bedoya Jose H |
Director |
– • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,375 |
24,192 |
|
- |
|
| Kalich Ronald B Sr |
Director |
– • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,375 |
27,085 |
|
- |
|
| Stich Joseph J. |
SVP, HR and GM, IVD |
• – – |
2022-01-04 |
4 |
AS |
$50.00 |
$125,000 |
D/D |
(2,500) |
45,839 |
|
-26% |
|
| Kalich Ronald B Sr |
Director |
– • – |
2021-12-31 |
4 |
A |
$48.15 |
$17,864 |
D/D |
371 |
25,710 |
|
- |
|
| Dantzker David |
Director |
– • – |
2021-12-31 |
4 |
A |
$48.15 |
$18,730 |
D/D |
389 |
31,210 |
|
- |
|
| Arens Timothy J. |
Chief Financial Officer |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,552 |
64,595 |
|
- |
|
| Arens Timothy J. |
Chief Financial Officer |
• – – |
2021-11-30 |
4 |
D |
$43.93 |
$28,555 |
D/D |
(650) |
60,043 |
|
- |
|
| Sides Teri Woodwick |
Senior VP and CMO |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,552 |
20,494 |
|
- |
|
| Sides Teri Woodwick |
Senior VP and CMO |
• – – |
2021-11-30 |
4 |
D |
$43.93 |
$19,153 |
D/D |
(436) |
15,942 |
|
- |
|
| Sultana Nusrath |
VP, Clinical Affairs |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
910 |
7,292 |
|
- |
|
| Sultana Nusrath |
VP, Clinical Affairs |
• – – |
2021-11-30 |
4 |
D |
$43.93 |
$18,934 |
D/D |
(431) |
6,382 |
|
- |
|
| Weber Gordon S. |
Sr. VP of Legal, GC and Sec. |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,552 |
11,265 |
|
- |
|
| Weber Gordon S. |
Sr. VP of Legal, GC and Sec. |
• – – |
2021-11-30 |
4 |
D |
$43.93 |
$19,153 |
D/D |
(436) |
6,713 |
|
- |
|
| Stich Joseph J. |
SVP, HR and GM, IVD |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,552 |
48,339 |
|
- |
|
| Stich Joseph J. |
SVP, HR and GM, IVD |
• – – |
2021-11-30 |
4 |
D |
$43.93 |
$30,795 |
D/D |
(701) |
43,787 |
|
- |
|
| Olson Charles W |
Senior VP of Bus Dev, Med Dev |
• – – |
2021-11-27 |
4 |
D |
$45.77 |
$15,974 |
D/D |
(349) |
38,472 |
|
- |
|
| Olson Charles W |
Senior VP of Bus Dev, Med Dev |
• – – |
2021-11-25 |
4 |
D |
$47.85 |
$22,537 |
D/D |
(471) |
38,821 |
|
- |
|
| Dantzker David |
Director |
– • – |
2021-11-03 |
4 |
D |
$56.56 |
$118,833 |
D/D |
(2,101) |
34,296 |
|
- |
|
| Dantzker David |
Director |
– • – |
2021-11-03 |
4 |
OE |
$21.31 |
$118,825 |
D/D |
5,576 |
36,397 |
|
- |
|
| Maharaj Gary R |
President & CEO |
• • – |
2021-11-01 |
4 |
AS |
$54.63 |
$327,904 |
D/D |
(6,000) |
146,811 |
|
-23% |
|
888 Records found
|
|
Page 4 of 36 |
|
|
